Holen Sie sich die Stockscreener-App
6.68
7.22%
0.45
Vorhandelsmarkt:
6.68
Schlusskurs vom Vortag:
$6.23
Offen:
$6.14
24-Stunden-Volumen:
116.86K
Relative Volume:
0.63
Marktkapitalisierung:
$69.03M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-1.4978
EPS:
-4.46
Netto-Cashflow:
$-27.47M
1W Leistung:
-7.48%
1M Leistung:
-33.80%
6M Leistung:
+56.81%
1J Leistung:
+35.50%
1-Tages-Spanne:
$6.107
$6.70
1-Wochen-Bereich:
$5.42
$7.90
52-Wochen-Spanne:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Vergleichen Sie CLNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.68 | 64.38M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
Analyst Maintains Buy Rating for CLNN with Stable Price Target | CLNN Stock News - GuruFocus
Promising Nanotechnology Stocks To Research – December 8th - Defense World
Clene to Present at the Emerging Growth Conference - The Manila Times
Clene to Present at the Emerging Growth Conference | Associated Press | syndication news - Enidnews.com
Exit Recap: How risky is Clene Inc Equity Warrant stock nowPortfolio Gains Summary & Capital Protection Trade Alerts - BỘ NỘI VỤ
Nanotechnology Stocks To Research – December 6th - Defense World
Nanotechnology Stocks To Watch Today – December 5th - Defense World
Clene to seek accelerated approval of ALS drug CNM-Au8 in 2026 - ALS News Today
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Clene (CLNN) and Costco (COST) - The Globe and Mail
Why Clene Inc. (84C0) stock stays resilient2025 Historical Comparison & Entry Point Strategy Guides - Newser
How Clene Inc. (84C0) stock reacts to new regulationsQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
How analysts revise price targets for Clene Inc. (84C0) stock2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - Newser
Best Nanotechnology Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Clene's (CLNN) Buy Rating Reiterated at D. Boral Capital - MarketBeat
Clene (CLNN) Gets a Buy from JonesTrading - The Globe and Mail
Benchmark reiterates Buy rating on Clene stock amid positive biomarker data By Investing.com - Investing.com South Africa
Benchmark reiterates Buy rating on Clene stock amid positive biomarker data - Investing.com
New Data from the NIH-Funded CNM-Au8® Expanded Access Program Provides Support for a Survival Benefit in ALS - Yahoo Finance
Should I hold or sell Clene Inc. Equity Warrant stock in 2025Earnings Summary Report & Free Real-Time Market Sentiment Alerts - Newser
A Look at Clene Inc (CLNN) Shares in the Recent Past Indicates Growth - Setenews
Why Clene Inc. Equity Warrant stock remains undervaluedBuy Signal & Expert Approved Momentum Trade Ideas - Newser
Clene Inc. (NASDAQ:CLNN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Clene’s (CLNN) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Clene Inc. (CLNN) 12.19% in After-hours: Positive ALS Biomarker Results Boosts Investor Sentiment - Stocks Telegraph
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8 - Investing News Network
Caring Brands, Inc. (CABR) 6.25% in After-hours: What’s Driving the Move? - Stocks Telegraph
D. Boral Capital Maintains Buy Rating for Clene (CLNN) | CLNN St - GuruFocus
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Clene (CLNN) Reports Promising Biomarker Results for ALS Treatme - GuruFocus
Clene’s CNM-Au8 Shows Promise in ALS Treatment, Projecting Significant Stock Upside - TipRanks
Clene Updates on CNM-Au8® ALS Program - TipRanks
Clene announces statistically significant ALS biomarker results - marketscreener.com
Clene announces significant reductions in NfL, GFAP when treated with CNM-Au8 - TipRanks
Clene Announces Positive Biomarker Results for CNM-Au8 - TipRanks
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8® - The Manila Times
Clene Inc Announces Significant ALS Biomarker Results - TradingView
Clene (Nasdaq: CLNN) reports NfL, GFAP drops in ALS as it targets 2026 accelerated NDA - Stock Titan
Will Clene Inc. (84C0) stock see insider accumulation2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Nanotechnology Stocks To Watch Now – December 1st - Defense World
Clene Inc. (CLNN) 8.53% in After-hours: Plans Update on CNM-Au8 ALS Program - Stocks Telegraph
Clene to Provide CNM-Au8® ALS Program Update - Investing News Network
Clene Inc. to Provide Update on CNM-Au8 Program in ALS during Investor Call on December 3, 2025 - Quiver Quantitative
Clene (Nasdaq: CLNN) to host Dec. 3 CNM-Au8 ALS program update webcast at 8:30 a.m. ET - Stock Titan
Nanotechnology Stocks To Watch NowDecember 1st - MarketBeat
Will Clene Inc. (84C0) stock beat value stocksJuly 2025 Retail & Safe Swing Trade Setups - Newser
Clene Inc. (CLNN) 7.18% in After-hours: Momentum Following Conference Announcement - Stocks Telegraph
Clene (CLNN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Top Nanotechnology Stocks To ConsiderNovember 27th - MarketBeat
Nanotechnology Stocks To ResearchNovember 29th - MarketBeat
Can Clene Reach Profitability by 2027? - AD HOC NEWS
Nanotechnology Stocks To Add to Your WatchlistNovember 28th - MarketBeat
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):